Lexington Partners’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-110,428
Closed -$1.42M 8
2022
Q2
$1.42M Buy
+110,428
New +$1.42M 0.73% 7